Blood Transfusion Devices Market to Grow with a CAGR of 5.68% through 2030
Surge in research and development activities is
expected to drive the Global Blood Transfusion Devices Market growth in the
forecast period, 2026-2030.
According to TechSci Research report, “Blood
Transfusion Devices Market - Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global Blood
Transfusion Devices Market stood at USD 4.80 Billion in 2024 and is anticipated
to grow with a CAGR of 5.68% through 2030. Initiatives taken by government
based on blood transfusion devices has led to favorable market conditions for
the Global Blood Transfusion Devices Market. Several factors contribute to the
growth of various blood transfusion devices products.
R&D initiatives have led to the development of a
wide range of innovative transfusion devices. These include automated blood
collection and separation systems, smart infusion pumps, and pathogen reduction
technologies that enhance blood safety by minimizing the risk of
transfusion-transmitted infections. Such advancements are critical in improving
clinical outcomes and are increasingly being adopted by hospitals and blood
banks worldwide. The integration of digital technologies into transfusion
systems is another key area of focus. Devices equipped with real-time
monitoring capabilities, barcoding, and RFID-based inventory tracking are
helping healthcare providers achieve greater accuracy and efficiency in donor
identification, blood compatibility verification, and transfusion tracking.
To improve donor mobilization and ensure a stable blood supply, several countries have launched national voluntary blood donation campaigns supported by mobile blood collection units and community outreach programs. These campaigns are frequently backed by digital platforms that facilitate donor registration, track donation history, and coordinate logistics, thereby increasing efficiency and participation. Governments also collaborate with NGOs, educational institutions, and corporate partners to expand the donor base and raise awareness about the importance of regular blood donation.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Blood Transfusion Devices Market”
The Global Blood Transfusion Devices Market is
segmented into product, end use, regional distribution, and company.
Based on Product, Infusion Devices have
emerged as the dominating segment in the Global Blood Transfusion Devices
Market in 2024. One of the primary factors contributing
to their dominance is their essential role in facilitating accurate and
consistent transfusion therapy. Infusion devices offer precise control over
flow rates and volumes, which is especially important during complex surgical
procedures, critical care interventions, or pediatric transfusions where even
slight dosing inaccuracies can have serious consequences. Their ability to minimize
transfusion errors has positioned them as indispensable tools in modern
healthcare delivery.
Based on Region, Asia Pacific have emerged as the fastest
growing region in the Global Blood Transfusion Devices Market in 2024. This is due
to its expanding healthcare infrastructure, rising surgical procedures, and
increasing awareness of blood safety. Rapid economic development across
countries such as China, India, Indonesia, and Vietnam has led to substantial
investments in healthcare facilities, enabling hospitals and diagnostic centers
to adopt advanced transfusion technologies. The region is witnessing a sharp
rise in trauma cases, chronic diseases, and surgical interventions all of which
contribute to increased demand for reliable blood transfusion systems.
Major companies operating in Global Blood Transfusion
Devices Market are:
- Immucor Inc.
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Terumo Corporation
- Grifols SA
- Kaneka Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Macopharma SA
- Ecomed Solutions, LLC.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“One of the most impactful applications of
nanotechnology is in pathogen detection and removal. Nanoscale filters and
nanomaterials are being integrated into transfusion systems to identify and
eliminate viruses, bacteria, and other pathogens from donated blood. These
nanofilters enhance the sterility of transfused blood without compromising the
viability of its components, thereby reducing the risk of
transfusion-transmitted infections (TTIs). This is particularly crucial in
regions with high demand for safe and rapid blood screening”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others), By Region and Competition, 2020-2030F”, has evaluated
the future growth potential of Global Blood Transfusion Devices Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Blood Transfusion Devices Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com